Teladoc Health (TDOC) Set to Announce Quarterly Earnings on Wednesday

Teladoc Health (NYSE:TDOC) is scheduled to be releasing its earnings data after the market closes on Wednesday, July 31st. Analysts expect Teladoc Health to post earnings of ($0.35) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Teladoc Health Trading Up 2.1 %

Shares of TDOC opened at $9.57 on Tuesday. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health has a 12-month low of $8.73 and a 12-month high of $30.15. The firm has a market capitalization of $1.62 billion, a PE ratio of -6.79 and a beta of 0.94. The stock’s fifty day simple moving average is $10.10 and its 200-day simple moving average is $13.93.

Insider Buying and Selling

In related news, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the transaction, the insider now directly owns 86,070 shares of the company’s stock, valued at $1,092,228.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Laizer Kornwasser sold 10,411 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the completion of the sale, the insider now directly owns 86,070 shares of the company’s stock, valued at $1,092,228.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Michael Willem Waters sold 5,793 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the sale, the chief operating officer now directly owns 64,881 shares of the company’s stock, valued at $823,339.89. The disclosure for this sale can be found here. Over the last three months, insiders sold 31,592 shares of company stock worth $383,854. 0.95% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Barclays dropped their price objective on Teladoc Health from $25.00 to $20.00 and set an “overweight” rating for the company in a report on Friday, April 26th. Oppenheimer dropped their price objective on Teladoc Health from $26.00 to $21.00 and set an “outperform” rating for the company in a report on Friday, April 26th. Bank of America dropped their price objective on Teladoc Health from $16.50 to $13.50 and set a “neutral” rating for the company in a report on Tuesday, May 14th. Canaccord Genuity Group dropped their price objective on Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a report on Friday, April 26th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Friday, April 26th. Thirteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, Teladoc Health presently has a consensus rating of “Hold” and a consensus target price of $17.97.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.